Currently out of the existing stock ratings of Cheng Li, 4 are a BUY (100%).
Analyst Cheng Li, currently employed at OPPENHEIMER,
Cheng Li has documented 8 price targets and ratings displayed on 1 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on WVE, Wave Life Sciences Ltd at 28-Oct-2026.
Analyst best performing recommendations are on WVE (WAVE LIFE SCIENCES LTD).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 16-Jul-2025
$15
$11.87 (379.23%)
$19
6 days ago
(12-Nov-2026)
Buy Since 19-Sep-2024
$18
$14.87 (475.08%)
$22
9 days ago
(09-Nov-2026)
2/5 (40%)
$14.52 (417.24%)
230
Buy Since 28-Jul-2025
$29
$25.87 (826.52%)
$32
21 days ago
(28-Oct-2026)
0/4 (0%)
$25.55 (740.58%)
Buy Since 19-Mar-2018
$23
$19.87 (634.82%)
$27
3 months 14 days ago
(04-Aug-2026)
7/16 (43.75%)
$17 (283.33%)
1135
Buy Since 23-Jun-2025
$12
$8.87 (283.39%)
$15
3 months 18 days ago
(31-Jul-2026)
3/7 (42.86%)
$6.49 (117.79%)
83
Which stock is Cheng Li most bullish on?
What Year was the first public recommendation made by Cheng Li?